For research use only
| Cat No. | ABC-TC1055 |
| Product Type | Human Kidney Cancer Cell Lines |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Product Code | SN-12C |
Tumorigenecity: Isoenzyme: Histopathology: carcinoma, renal cellSubculture: Split ratio: Media change: Reverse transcritase: Production
Tumorigenecity: Isoenzyme: Histopathology: carcinoma, renal cellSubculture: Split ratio: Media change: Reverse transcritase: Production.
| Product Code | SN-12C |
| Species | Human |
| Cat.No | ABC-TC1055 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Kidney Cancer Cell Lines |
| Stock | Out of stock |
For research use only
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
White SM, Avantaggiati ML, Nemazanyy I, et al. YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells. Dev Cell. 2019;49(3):425-443.e9. doi:10.1016/j.devcel.2019.04.014
